Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IL-15 with TIL Therapy in Metastatic Melanoma
NCT01369888Phase 2Terminated
- Sponsor
- National Cancer Institute
- Start
- May 2011
- Primary completion
- May 2014
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of recombinant human interleukin-15 in melanoma, sponsored by National Cancer Institute. Started May 2011; status: terminated.
02
Drugs
recombinant human interleukin-15
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT01369888.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01369888.